![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
X
01 Novartis Pharmaceuticals Australia Pty Limited (6)
02 Novartis Pharmaceuticals Corporation (8)
03 Novartis South Africa (Pty) Ltd (2)
01 CAP (2)
02 CAPSULE (2)
03 CAPSULE;ORAL (3)
04 TABLET FOR SUSPENSION (1)
05 TABLET, FOR SUSPENSION;ORAL (1)
06 TABLET; ORAL SUSPENSION (1)
07 Blank (6)
01 Originator (2)
02 Prescription (3)
03 RX (3)
04 Blank (8)
01 Rafinlar 50 mg (1)
02 Rafinlar 75 mg (1)
03 TAFINLAR (8)
04 Tafinlar (6)
01 Australia (6)
02 Canada (3)
03 South Africa (2)
04 USA (5)